Aposense Ltd. (Aposense), is a molecular imaging and drug development company engaged in the development of innovative products, diagnostics, and therapies based on the identification and targeting of cells undergoing apoptosis (programmed cell death). It is formerly known as Neurosurvival Technologies Ltd. (NST). Its product pipeline is based on its patented Aposense platform technology. Aposense is a set of small and rationally-designed molecules for clinical use. The company is focused on developing Aposense products in the molecular imaging and the therapeutic areas. Aposense is head quartered in Petach-Tikva, Israel.
Recently Aposense and IBA Sign Strategic Collaboration to Commercialize Aposense ML-10 for Molecular Imaging of Apoptosis.